On this episode of the CEO Podcast, Clint sat down with Will Lewis, the CEO of Innsmed, a company dedicated to developing innovative drugs for patients facing serious and rare diseases. Will shares his journey to becoming CEO, the transformative growth of Innsmed, and the intricate process of drug development, including the lengthy timelines and significant financial investments involved. They discuss the importance of patient experience, the ethical considerations in drug development, and the role of artificial intelligence in streamlining processes. Will also offers insights into leadership, mentorship, and the values that drive his team to make a meaningful difference in patients' lives. 

Timestamps:
00:00 Introduction to Innsmed and CEO Journey
00:38 Overview of Innsmed's Mission
01:39 The Drug Development Process
04:04 The Necessity of the 15Year Process
06:38 Expedited Drug Development During COVID19
08:12 Choosing Which Diseases to Target
10:51 The Future of Curing Diseases
12:55 The Role of Artificial Intelligence in Drug Development
16:21 A Day in the Life of the CEO
18:05 Leadership Philosophy and Values
20:18 Reading Recommendations
21:22 Impact of the Macro Economic Environment
24:02 Financing in the Biotech Industry
27:03 Intellectual Property and Competition
30:37 Closing Thoughts on Mentorship and Opportunities